Speaker

Alexei Pushechnikov

CTO, Mair Therapeutics

Alexei Pushechnikov, CTO at Mair Therapeutics, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Advancing Lysosomal Ion Channel Programs from Early Discovery into Confident Lead Optimization”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

Ion Channel-Targeted Drug Development Summit
23–24 Sept 2026Boston, United States of America
- SpeakerAdvancing Lysosomal Ion Channel Programs from Early Discovery into Confident Lead Optimization
- PanelPanel: Comparing Modality Selection Decisions to Match Biology & Indication RequirementsWith Stefan McDonough, Alejandro Amador, Fabricio Simao, Edward Humphries

More speakers at Ion Channel-Targeted Drug Development Summit

Christopher Ahern
Professor - Molecular Physiology & Biophysics, The University of Iowa
Bruce Bean
Professor of Neurobiology, Harvard Medical School
Gulayse Dunn
Senior Principal Scientist, Novartis
Dan Elbaum
Chief Scientific Officer, QurAlis Corp.
Jim Ellis
Chief Scientific Officer, Nocion Therapeutics, Inc.
Kelly Gatfield
Group Leader & Scientific Leader, GlaxoSmithKline

See all 16 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Alexei Pushechnikov, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].